SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.
Frequently asked questions
What sector does SpectraCure AB (SPEC) operate in?
SpectraCure AB belongs to the Healthcare sector and operates in the Medical Devices industry.
What is SpectraCure AB (SPEC) current stock price?
As of the latest data, SpectraCure AB stock price is SEK 0.04, with a previous close of SEK 0.04. SpectraCure AB gained SEK 0.00 in the last trading session, representing a 4.58% increase.
What is SpectraCure AB (SPEC) current market capitalization?
SpectraCure AB market cap is approximately 28.54 million.
What is SpectraCure AB (SPEC) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.14.
What is SpectraCure AB (SPEC) EBITDA?
SpectraCure AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -5.72 million.
Does SpectraCure AB (SPEC) pay dividends?
No. SpectraCure AB does not pay a dividend.
What is SpectraCure AB (SPEC) beta (volatility) score?
SpectraCure AB has a beta of 0.392, indicating lower volatility than the overall market.